In essence, our research suggested that EMP1 amplifies the tumorigenic attributes of PC both in vitro and in vivo, encompassing facets like cellular proliferation and metastatic potential orchestrated through the PI3K/AKT molecular conduit (Fig. S9). The gene discussed is AKT1; the disease is pachyonychia congenita.